SEC Filings

Filing date Form Description Filing Group View
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

Registration Statements
View HTML
424B3

Form of prospectus reflecting facts events constituting substantive change from last form

Registration Statements
View HTML
424B3

Form of prospectus reflecting facts events constituting substantive change from last form

Registration Statements
View HTML
FWP

FWP

Other
View HTML
DRS/A

mendment to a previously filed DRS

Registration Statements
View HTML
DRS/A

mendment to a previously filed DRS

Registration Statements
View HTML
DRS/A

mendment to a previously filed DRS

Registration Statements
View HTML
D

Notice of Exempt Offering of Securities

Other
View HTML
8-A12B

Registration of certain classes of securities 12(b) of the Securities Exchange Act

Registration Statements
View HTML
8-A12B

Registration of certain classes of securities 12(b) of the Securities Exchange Act

Registration Statements
View HTML

Data provided by Kaleidoscope.

Technology

PolyPid’s PLEX targeted drug delivery platform enables localized, controlled, continuous release of medication over prolonged periods of time for better patient outcomes.

Read More >
D-PLEX100

D-PLEX100

Provides safe and effective local antibiotic protection against SSI (surgical Site Infection) at the needed tissues or organs by administration during surgical procedures.

Read More >
D-PLEX1000

D-PLEX1000

Comprised of antibiotic eluting ß tri-calcium phosphate (ßTCP) granules, designed for bone related infections applications.

Read More >